FRESH HOPE FOR DEMENTIA DRUG
Daily Record|July 04, 2024
Disease-modifying treatment approved in US
MARTIN BAGOT
FRESH HOPE FOR DEMENTIA DRUG

A NEW Alzheimer's drug has been approved in the US amid growing calls for the NHS to improve early diagnosis so Brits can benefit from the treatment.

UK regulators are still reviewing Donanemab, the world's first disease-modifying treatments for dementia, approved by the US Food and Drug Administration on Tuesday.

Bu hikaye Daily Record dergisinin July 04, 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye Daily Record dergisinin July 04, 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.